<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>therapeutic targeting &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/therapeutic-targeting/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 17:33:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>therapeutic targeting &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>ANGPTL3-Integrin α5 Link Fuels Diabetic Retinopathy Leakage</title>
		<link>https://bioengineer.org/angptl3-integrin-%ce%b15-link-fuels-diabetic-retinopathy-leakage/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 17:32:54 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[ANGPTL3-integrin α5 axis]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Diabetic Retinopathy]]></category>
		<category><![CDATA[Molecular Pathways]]></category>
		<category><![CDATA[Molecular Pathways** **Açıklama:** 1. **Diabetic Retinopathy:** Makalenin ana konusu ve araştırmanın odaklandığı hastalık. 2. **ANGPTL3-integrin α]]></category>
		<category><![CDATA[Retinal Vascular Leakage]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<category><![CDATA[therapeutic targets]]></category>
		<guid isPermaLink="false">https://bioengineer.org/angptl3-integrin-%ce%b15-link-fuels-diabetic-retinopathy-leakage/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have unveiled the crucial role of the ANGPTL3-integrin α5 axis in driving retinal vascular leakage, a key feature of diabetic retinopathy (DR). This condition, which affects millions worldwide, is a leading cause of vision loss among diabetes patients. The team, led by Dr. Jing Ke, examined how alterations in this [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318454</post-id>	</item>
		<item>
		<title>Pancreatic Tumor Microenvironment: Heterocellular Interactions Explored</title>
		<link>https://bioengineer.org/pancreatic-tumor-microenvironment-heterocellular-interactions-explored/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 18 Jan 2026 18:50:41 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[fibroinflammatory microenvironment]]></category>
		<category><![CDATA[Heterocellular crosstalk]]></category>
		<category><![CDATA[heterocellular interactions]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **pancreatic cancer microenvironment]]></category>
		<category><![CDATA[pancreatic cancer]]></category>
		<category><![CDATA[stroma-targeted therapy]]></category>
		<category><![CDATA[Stromal interactions]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/pancreatic-tumor-microenvironment-heterocellular-interactions-explored/</guid>

					<description><![CDATA[In recent years, the intricate relationship between tumor cells and their surrounding microenvironment has become a focal point in cancer research. This is particularly evident in pancreatic cancer, where the fibroinflammatory microenvironment plays a pivotal role in disease progression and treatment response. As researchers delve deeper into the complex cellular interactions that comprise this environment, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318009</post-id>	</item>
		<item>
		<title>PHGDH: Navigating Cancer’s Metabolic and Therapeutic Challenges</title>
		<link>https://bioengineer.org/phgdh-navigating-cancers-metabolic-and-therapeutic-challenges/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 15:27:43 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[and keywords]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[Cancer metabolic adaptation** **Explanation:** 1. **PHGDH cancer metabolism:** Directly names the key enzyme (PHGDH) and its central role in cancer metabolism]]></category>
		<category><![CDATA[cancer therapeutics]]></category>
		<category><![CDATA[here are 5 suitable tags: **PHGDH cancer metabolism]]></category>
		<category><![CDATA[metabolic plasticity]]></category>
		<category><![CDATA[metastasis mechanisms]]></category>
		<category><![CDATA[Metastasis paradox]]></category>
		<category><![CDATA[PHGDH in cancer]]></category>
		<category><![CDATA[Serine biosynthesis]]></category>
		<category><![CDATA[the article's core focus. 2. **Metabolic plasticity:** Highlights a major theme discussed throughout the text - the ability of cancer cells to]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<category><![CDATA[title]]></category>
		<guid isPermaLink="false">https://bioengineer.org/phgdh-navigating-cancers-metabolic-and-therapeutic-challenges/</guid>

					<description><![CDATA[In the rapidly evolving field of oncology, one molecule is emerging as a pivotal player in the intricate balance of cancer metabolism and progression: phosphoglycerate dehydrogenase (PHGDH). This enzyme, crucial for the serine biosynthesis pathway, has garnered attention for its role in tumor growth and metastasis. Researchers Hao, Li, and Lu explore the multifaceted functions [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313777</post-id>	</item>
		<item>
		<title>Hipk Kinase Boosts Apoptosis by Activating Dronc</title>
		<link>https://bioengineer.org/hipk-kinase-boosts-apoptosis-by-activating-dronc/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 20:37:59 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Apoptosis regulation]]></category>
		<category><![CDATA[Dronc activation]]></category>
		<category><![CDATA[Hipk kinase]]></category>
		<category><![CDATA[Kinase-caspase interaction]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<guid isPermaLink="false">https://bioengineer.org/hipk-kinase-boosts-apoptosis-by-activating-dronc/</guid>

					<description><![CDATA[In a groundbreaking advancement in the realm of molecular biology and cell death, researchers have uncovered a pivotal mechanism by which the homeodomain-interacting protein kinase (Hipk) enhances programmed cell death, or apoptosis, through the stabilization of an essential apoptotic enzyme, Dronc. This discovery sheds new light on the intricate control of cellular fate, offering promising [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">308562</post-id>	</item>
		<item>
		<title>GRP94 Regulates TGF-beta Maturation via Furin</title>
		<link>https://bioengineer.org/grp94-regulates-tgf-beta-maturation-via-furin/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 16 Dec 2025 01:39:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Chaperone-protease axis]]></category>
		<category><![CDATA[GRP94-furin interaction]]></category>
		<category><![CDATA[M2 macrophages]]></category>
		<category><![CDATA[TGF-beta maturation]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<guid isPermaLink="false">https://bioengineer.org/grp94-regulates-tgf-beta-maturation-via-furin/</guid>

					<description><![CDATA[In the rapidly evolving landscape of cellular biology, researchers continue to uncover intricate mechanisms that govern cellular function and immune regulation. A groundbreaking study recently published in Cell Death Discovery sheds new light on the pivotal role of the chaperone protein GRP94 in regulating the maturation of transforming growth factor-beta (TGF-beta) within human primary M2 [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">308190</post-id>	</item>
		<item>
		<title>HIF-1 Pathway’s Impact on LC-COPD Revealed</title>
		<link>https://bioengineer.org/hif-1-pathways-impact-on-lc-copd-revealed/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 21 Nov 2025 23:35:16 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[HIF-1 signaling pathway]]></category>
		<category><![CDATA[Hypoxic tumor microenvironment]]></category>
		<category><![CDATA[LC-COPD comorbidity]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<guid isPermaLink="false">https://bioengineer.org/hif-1-pathways-impact-on-lc-copd-revealed/</guid>

					<description><![CDATA[Recent advances in cancer and respiratory disease research have unveiled a compelling link between the hypoxia-inducible factor 1 (HIF-1) signaling pathway and the devastating impacts of lung cancer associated chronic obstructive pulmonary disease (LC-COPD). A new study from researchers Zheng and Jin, published in the Journal of Cancer Research and Clinical Oncology, explores the intricate [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">299776</post-id>	</item>
		<item>
		<title>SLC7A1: New Therapeutic Target for High-Grade Meningioma</title>
		<link>https://bioengineer.org/slc7a1-new-therapeutic-target-for-high-grade-meningioma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 03 Nov 2025 13:47:13 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[amino acid transport]]></category>
		<category><![CDATA[high-grade meningioma]]></category>
		<category><![CDATA[SLC7A1]]></category>
		<category><![CDATA[therapeutic targeting]]></category>
		<category><![CDATA[tumor metabolism]]></category>
		<guid isPermaLink="false">https://bioengineer.org/slc7a1-new-therapeutic-target-for-high-grade-meningioma/</guid>

					<description><![CDATA[In a groundbreaking study that could reshape the therapeutic landscape for aggressive brain tumors, researchers have identified the amino acid transporter SLC7A1 as a pivotal target in high-grade meningioma treatment. High-grade meningiomas, notorious for their aggressive behavior and resistance to conventional therapy, have remained a clinical challenge. The latest research uncovers molecular insights that promise [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">290449</post-id>	</item>
	</channel>
</rss>
